From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

Bearcast
premium content

Tom Winnifrith Bearcast - distracted by Warwick School matters

I refer to this. Then I discuss Totally (TLY), Versarien (VRS), Metal Tiger (MTL), Advanced Oncotherapy (AVO), Wandisco (WAND) and Flip Flop's Kavango (KAV)
BMV
premium content

Bluebird Merchant Ventures – “delighted” with scoping study, we can understand why! Shares to double well before Christmas?...

Bluebird Merchant Ventures (BMV) states that it “is delighted to announce a Scoping Study for its Kochang and Gubong gold projects in South Korea” and the shares have currently responded up to just above 2p. But there looks clear potential for much more to come.
VRCI

Verici Dx – emphasises “Certificate of Compliance”, but what’s the financial outlook?

Previously writing on transplant platform company Verici Dx (VRCI), in September with the shares falling to 17.5p I reviewed was the fundraise for accelerated progress or to avert cash crunch ahoy?, concluding continue to avoid. The shares most recently closed at 7.5p, but what of them currently up 20% today on the back of a “CLIA Certificate of Compliance” announcement.

Madness

#BoycottHershey – go woke go broke on #InternationalWomensDay

One good reason to boycott the America chocolate company and all its teeth rotting products is that it fired workers in the US who refused to take a covid vaccine. But today its International Women’s Day (March 8) Canadian operation has served up another. Meet Fae Johnstone who has been appointed and paid to be one of its five women ambassadors on this day. Remember this is the socialist, woke hell hole that is Canada. Have you guessed yet?
HLN
premium content

How is Haleon - the spin-off from GSK plc - getting on?

A busy day on the London market, but I will write about the consumer health company Haleon (HLN), which many of you will remember split out from GSK (GSK) back in July last year. Whilst its shares remain above the level when I last wrote about it in November last year, the stock is down 4% today despite apparently having an "extraordinary year” as being the “first listed company 100% invested” in its specific space.

VIC
premium content

Victorian Plumbing – AGM trading update, how “strong” really is the trading performance?

Online bathroom retailer Victorian Plumbing (VIC) has announced that it “has maintained the strong start to the financial year and the group has delivered 10% revenue growth year to date, combined with an improvement in gross margin and marketing spend efficiency versus the comparative period last year”. So what of a share price currently up to 87p?
VRS
premium content

Letter to AIM Regulation – Versarien’s self confessed breach of AIM Rule 11

As it struggles to remain solvent, Versarien (VRS) has, in effect, admitted breaching AIM Rule 11 in its annual report. I have written to the Oxymorons asking for formal censure of the company and its loathsome CEO Neill Ricketts.
PHE
premium content

Letter to FCA – market abuse by Howard White regarding Powerhouse Energy

Following up on this expose HERE regarding the dumping of shares in Powerhouse Energy (PHE) by Howard White and his two sons I have written to the FCA asking it to investigate whether Mr White is guilty of market abuse as a result of market manipulation. I believe that without any doubt, he is.
HAYD
premium content

Haydale – Another Round Of Awful Interims As The Cash Runs Low Yet Again

AIM-listed Haydale (HAYD) – another graphene outfit on AIM besides the disaster that is Versarien (VRS) – announced interims to December 31 this morning. The company boasted adjusted operating losses of £1.89 million, to which my reaction is one of Warren Buffett: who do they think they are deluding – their investors, or themselves? The market was not fooled, marking the stock down marginally.
Bearcast
premium content

Tom Winnifrith BONUS bearcast: Advanced Oncotherapy, 9 weeks from death & now a full blown death spiral in place AFTER today's £5m financing

Was there any insider dealing before a mid afternoon financing update from Advanced Oncotherapy (AVO). A 32% share price fall suggests that the Pope is also a Catholic. I discuss the new £4.975 million financing which still leaves Advanced only 9 weeks away from running out of cash and the full blown death spiral which cheats its way around par value rules but which will crush the share price.
XSG
premium content

Xeros Technology – Director of Finance appointment; following recent lack of progress detail and EBITDA miss, good luck chap!

Xeros Technology (XSG) states that it is “delighted” to promote Alex Tristram to Director of Finance and Company Secretary, with he having “made a significant contribution to Xeros over his time with the company and his leadership and financial acumen make this a very natural appointment”. Er, what about the previous finance director though?
MBT

Mobile Tornado – discounted subscription and debt conversion for “business development”?

Mobile Tornado Group (MBT) has issued a “Subscription, Debt Conversion and Trading Update” announcement including that its moves “will allow us to accelerate our business development activities further, with the recruitment of additional sales professionals in key markets and the execution of a much more intensive outreach campaign… and is now actively engaged with a number of potential new partners and customers”. So what of a share price currently approaching 5% lower at 2p?
Bearcast
premium content

Tom Winnifrith Bearcast: it is not Sunny in Wrexham it really is post industrial grim

On this St David's Day myself and little Jaya went to Wrexham and I describe just how grim it is. Do not believe the hype. Then it is onto Cellular Goods (CBX), Guild ESports (GILD), Anglesey Mining (AYM), Versarien (VRS), Canadian Overseas Petroleum (COPL) and Advanced Oncotherapy (AVO) where events have overtaken me requiring a follow up podcast which I shall do now.
AVO
premium content

BREAKING: Advanced Oncotherapy shares collapsing – statement needed asap as the Sheriff vindicated yet again

The shares are now just 4.25p, down another 32% today. The bare facts are that Advanced Oncotherapy (AVO) is running on fumes. If it does not raise fresh funding asap the Fat Lady will be called in for an emergency gig very soon indeed. The problem, as we have noted many times, is that par value is 25p.
RKT
premium content

I am still a Reckitt Benckiser shares fan

I guess it depends how old you are whether brands such as Harpic, Vanish, Dettol and Finish have a lot more relevance for you than Durex or baby food ones, but at least the FTSE 100’s Reckitt (RKT) has a bunch of interesting global brands. I last loved the stock up just over four months ago and since then it has gone almost perfectly sideways. What are the group’s prospects like for 2023 (and beyond)?

NEXS
premium content

Nexus Infrastructure – details tender offer and what’s the outlook from here?

Last month Nexus Infrastructure (NEXS) announced that it had completed the sale of its TriConnex (multi-utility networks) and eSmart Networks (renewable and electric vehicle charging infrastructure) businesses for £77.7 million and that “a circular containing details of… tender offer as well as a notice convening a general meeting of shareholders is expected to be published shortly”. This has now been published and so what of a current 162p share price, £73.8 million market cap?
INL
premium content

Inland Homes from bad to worse

The stench at Inland Homes (INL) just ratcheted up to top gear with the shock resignation of all three of its non exec chairman Simon Bennett, Carol Duncumb and Brian Johnson as a stack of undeclared related party deals have emerged. That may well be one of the reasons why, yesterday, Inland warned that there would be a delay in the publication of its annual results.
VRS
premium content

The delayed Versarien annual report part 2 – more heroic assumptions on the non graphene businesses

Finally the delayed annual report arrived yesterday allowing us to see what exactly cash strapped Versarien (VRS) was hiding in its abridged annual results. Yesterday I showed the wholly unrealistic claims regarding graphene which were made to avoid huge intangible writedowns. Now to the non-graphene businesses which is almost as ludicrous.
HIK

This Respected Outfit Supplying Loads of Drugs could Have a Healthy Future

Hello Share Takers. Medical companies are still high on my list of sectors that could outperform the market this year. A company I’ve not considered before but which has a healthy record is Hikma Pharmaceuticals (HIK).
ESYS

essensys – states targeting “accelerated implementation of plan for profit and cash generation”. I wonder why...

Flexible workspace technology company essensys (ESYS) has issued a trading update emphasising half-year “Revenue growth of 18%, accelerated implementation of plan for profit and cash generation”. So what of a current share price response slightly lower to 57p?
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

 

ANP

Anpario – a recovery Buy?...

Thursday »

Cat_Fixing_Lightbulb

Bearcast issue update: all should be well

 

ORCP

Oracle Power: Cynical Foul

Time left: 02:44:53